AstroGenetix News

ASTROGENETIX AND NASA SIGN AGREEMENT TO CONTINUE DEVELOPING MEDICINES IN SPACE TO SAVE LIVES ON EARTH

JElbaum — Wed, 08 Feb 2012 10:13:32 -0500

Astrogenetix Corporation, a subsidiary of Astrotech Corporation (NASDAQ: ASTC), has entered into a Space Act Agreement (SAA) with NASA, (National Aeronautics and Space Administration). This SAA commits to providing the critical resources needed to continue utilizing the International Space Station (ISS) and to further the development of important on-orbit microgravity vaccines and therapeutic drug experiments.

Wed, 31 Dec 1969 19:00:00 -0500

n/a

Wed, 31 Dec 1969 19:00:00 -0500

n/a

Wed, 31 Dec 1969 19:00:00 -0500

n/a

Wed, 31 Dec 1969 19:00:00 -0500

n/a

Wed, 31 Dec 1969 19:00:00 -0500

n/a

Wed, 31 Dec 1969 19:00:00 -0500

n/a

Wed, 31 Dec 1969 19:00:00 -0500

n/a

Wed, 31 Dec 1969 19:00:00 -0500

n/a

Wed, 31 Dec 1969 19:00:00 -0500

n/a

ASTROGENETIX TO CONDUCT MRSA RESEARCH ON SHUTTLE MISSION

admin — Thu, 26 Mar 2009 15:52:07 -0400

Astrogenetix, Inc., a subsidiary of the Astrotech Corporation, today announced it is conducting novel pharmaceutical research aboard Shuttle Discovery (STS-119) on NASA mission 15A scheduled to launch this evening and destined for the International Space Station (ISS).

SPACEHAB FINALIZES AGREEMENT WITH NASA

testcontenteditor — Fri, 27 Feb 2009 15:48:06 -0500

SPACEHAB Incorporated, (NASDAQ: SPAB), today announced that the company has finalized a Space Act Agreement with the National Aeronautics and Space Administration (NASA) for use of the International Space Station (ISS), a designated U.S. National Laboratory, for research, development and industrial processing purposes. This agreement marks the beginning of SPACEHAB's new subsidiary BioSpace Technologies, Inc.

SEND VALIDATION OF SALMONELLA VACCINE TARGET TO THE SPACE STATION

admin — Wed, 18 Mar 2009 15:54:03 -0400

A partnership between Space Florida and SPACEHAB’s new biotech subsidiary BioSpace Technologies Inc. is paving the way to develop multiple vaccine targets on the International Space Station (ISS).

SPACEHAB CHIEF SPEAKS AT U.S. HOUSE

admin — Fri, 13 Mar 2009 13:34:41 -0400

SPACEHAB Incorporated, (NASDAQ: SPAB), a provider of commercial space services, today announced that Thomas B. Pickens, III, SPACEHAB Chairman and Chief Executive Officer, served as a key witness today in a hearing with the U.S. House of Representatives Committee on Science and Technology, Subcommittee on Space and Aeronautics, regarding NASA's International Space Station (ISS) Program: Status and Issues.

SPACEHAB TEAMS WITH STATE OF FLORIDA

admin — Fri, 13 Mar 2009 13:42:43 -0400

SPACEHAB Incorporated, (NASDAQ: SPAB), a provider of commercial space services, along with Florida Governor Charlie Crist, recently announced the Company's partnership with the state of Florida to establish a space-based, biotech corridor that stretches from the International Space Station (ISS) to Earth-based Florida facilities and resources such as the Space Life Sciences Lab at NASA's John F. Kennedy Space Center (KSC).

SPACEHAB ANNOUNCES FORMATION OF COUNCIL

admin — Tue, 17 Mar 2009 10:40:19 -0400

SPACEHAB Incorporated, (NASDAQ: SPAB), a provider of commercial space services, today announced the formation of a new Science Advisory Council, an elite team of scientists, physicians, and microgravity specialists who provide strategic guidance and technical insight as the Company advances its identified microgravity processing initiatives through its new subsidiary, SPACEHAB Microgravity Sciences, Inc.